OTHER SHOWS

Seminars 2019 (New)

EDUCATIONAL PARTNER

  • RVC_

Loading

The Impact of Fortetropin Supplementation on Dogs Recovering from TPLO Surgery

Nov 08, 2019
Innovation Showcase 1

The impact of the nutraceutical, Fortetropin on muscle atrophy in dogs recovering from TPLO surgery was evaluated in a randomized, double-blinded, placebo-controlled study involving 100 dogs. Dogs in the Fortetropin and placebo groups were evaluated at t=0, 8, 12 weeks. Following surgery, dogs experienced 8 weeks of forced exercise restriction, gradually resuming physical activity during weeks 9 - 12. Evaluation parameters included: thigh circumference measurements, stance force analysis, serum myostatin and C-reactive protein concentration measurements, ultrasonographic assessments of thigh and epaxial muscle thickness, and muscle condition scoring. During the period of forced exercise restriction from week 0 - 8, when comparing Fortetropin® supplementation to placebo: 1) Fortetropin® prevented a rise in serum myostatin levels, 2) Fortetropin® minimized the loss of muscle mass as measured by thigh circumference and 3) Fortertropin® supplemented dogs had a more significant improvement in percent of weight supported by the affected limb.

  • After TPLO surgery:
  • 1) Fortetropin® prevented a rise in serum myostatin levels
  • 2) Fortetropin® minimized the loss of muscle mass as measured by thigh circumference
  • 3) Fortertropin® supplemented dogs had a more significant improvement in percent of weight supported by the affected limb.
Speakers
Joseph Mannello, CEO - MYOS RENS Technology, Inc.
 

Education Partner

  • RVC_

 

Platinum Sponsors

  • IDEXX

 

Gold Sponsors

  • VCA-Antech-Sound
  • Hill's Pet Nutrition
  • Banfield Pet Hospital
  • ElleVet Sciences

 

Silver Partners

  • VEG

 

Associations

  • NYSVMS
  • VHMA
  • NYCVMA
  • NJVTA
  • LIVMA